- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Cardihab nudges investors for $1.35m
Multi-university venturing fund Uniseed has invested $500,000 in smartphone cardiac monitoring developer Cardihab.
Sep 22, 2017Interface Polymers bags $2.6m
Interface Polymers has secured funding as it prepares to shape its materials adhesive concept into a commercial product.
Sep 22, 2017Medaphor picks up Intelligent Ultrasound
Ultrasound simulator developer Medaphor will pay up to $4.9m in shares to acquire University of Oxford spinout Intelligent Ultrasound.
Sep 22, 2017Contrary Capital boots up fund
The fund, which has already made its first investments, will offer between $50,000 and $200,000 to both spinouts and student startups.
Sep 22, 2017Analysis: MissFresh gets $230m delivered
Returning investor Tencent contributed to a round that upped the total raised by the online fresh produce retailer to over $400m
Sep 22, 2017Disarm persuades investors for series A
AbbVie Ventures is among the backers of a $30m series A round for Disarm Therapeutics, a biotechnology spinout from Washington University in St Louis.
Sep 21, 2017The Engine accelerates to $200m
The Engine has already made seven investments in a bid to commercialise technologies that require a longer-term view than most.
Sep 20, 2017IP Group secures 96.5% of Touchstone support
The commercialisation firm has secured support for a takeover from shareholders who hold 96.5% between them in its peer Touchstone Innovations.
Sep 20, 2017Ovensa scores $1.38m in capital
Uqar spinout Ovensa has obtained $1.38m of additional funding from investors including commercialisation firm Aligo Innovation.
Sep 19, 2017Matroid meets Intel in $10m round
Intel and New Enterprise Associates have co-led a series A round for computer vision startup Matroid, based on research by Stanford professor Reza Zadeh.
Sep 19, 2017Immunocore takes in up to $40m
Bill & Melinda Gates Foundation will invest up to $40m in the biological drug developer, which raised $320m in an Eli Lilly-backed round two years ago.
Sep 19, 2017Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


